NPT-100-18-A

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameNPT-100-18-A
Drug Alias NameNPT100-18ANPT-100-18-A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSynuclein alpha inhibitors
TargetsSynuclein alpha
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNeuropore Therapies Inc
China Registration ClassN/A

Develop Information

Active CompaniesNeuropore Therapies Inc
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A